Watch This | Biden's support for vaccine patent waiver 'dangerous': expert
U.S. President Joe Biden last week backed a call to waive patent protection for COVID-19 vaccines, angering pharmaceutical companies and triggering opposition from several Western countries.
DotDotNews recently invited Aditya Vijay Berlia, an Indian expert in the pharmaceutical sector for an exclusive interview on this issue.
What does the vaccine patent waiver mean? Is it going to address the global shortage of COVID-19 vaccines? Why is so strongly opposed by the pharmaceutical sector? The current epidemic situation in India has concerned us all. How is India's vaccine production affected by the latest virus surge and how is the vaccination situation in the country? Watch the video to find out.
上周，美國政府宣布支持放棄新冠疫苗專利保護，該舉措引發了多家製藥公司和部分西方國家的反對。日前，點新聞DotDotNews連線來自印度的醫藥領域專家Aditya Vijay Berlia，與他進行了一次專訪，討論這個熱議話題。